Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action. Issue 5 (3rd March 2020)
- Record Type:
- Journal Article
- Title:
- Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action. Issue 5 (3rd March 2020)
- Main Title:
- Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action
- Authors:
- Jung, Yong Hun
Mamadjonov, Najmiddin
Lee, Hyoung Youn
Jeung, Kyung Woon
Lee, Byung Kook
Youn, Chun Song
Heo, Tag
Min, Yong Il - Abstract:
- Abstract : Background: We previously reported that pralidoxime facilitated restoration of spontaneous circulation by potentiating the pressor effect of epinephrine. We determined the optimal dose of pralidoxime during cardiopulmonary resuscitation and evaluated the involvement of α‐adrenoceptors in its pressor action. Methods and Results: Forty‐four pigs randomly received 1 of 3 doses of pralidoxime (40, 80, or 120 mg/kg) or saline placebo during cardiopulmonary resuscitation, including epinephrine administration. Pralidoxime at 40 mg/kg produced the highest coronary perfusion pressure, whereas 120 mg/kg of pralidoxime produced the lowest coronary perfusion pressure. Restoration of spontaneous circulation was attained in 4 (36.4%), 11 (100%), 9 (81.8%), and 3 (27.3%) animals in the saline, 40, 80, and 120 mg/kg groups, respectively ( P <0.001). In 49 rats, arterial pressure response to 40 mg/kg of pralidoxime was determined after saline, guanethidine, phenoxybenzamine, or phentolamine pretreatment, and the response to 200 mg/kg pf pralidoxime was determined after saline, propranolol, or phentolamine pretreatment. Pralidoxime at 40 mg/kg elicited a pressor response. Phenoxybenzamine completely inhibited the pressor response, but guanethidine and phentolamine did not. The pressor response of pralidoxime was even greater after guanethidine or phentolamine pretreatment. Pralidoxime at 200 mg/kg produced an initial vasodepressor response followed by a delayed pressor response.Abstract : Background: We previously reported that pralidoxime facilitated restoration of spontaneous circulation by potentiating the pressor effect of epinephrine. We determined the optimal dose of pralidoxime during cardiopulmonary resuscitation and evaluated the involvement of α‐adrenoceptors in its pressor action. Methods and Results: Forty‐four pigs randomly received 1 of 3 doses of pralidoxime (40, 80, or 120 mg/kg) or saline placebo during cardiopulmonary resuscitation, including epinephrine administration. Pralidoxime at 40 mg/kg produced the highest coronary perfusion pressure, whereas 120 mg/kg of pralidoxime produced the lowest coronary perfusion pressure. Restoration of spontaneous circulation was attained in 4 (36.4%), 11 (100%), 9 (81.8%), and 3 (27.3%) animals in the saline, 40, 80, and 120 mg/kg groups, respectively ( P <0.001). In 49 rats, arterial pressure response to 40 mg/kg of pralidoxime was determined after saline, guanethidine, phenoxybenzamine, or phentolamine pretreatment, and the response to 200 mg/kg pf pralidoxime was determined after saline, propranolol, or phentolamine pretreatment. Pralidoxime at 40 mg/kg elicited a pressor response. Phenoxybenzamine completely inhibited the pressor response, but guanethidine and phentolamine did not. The pressor response of pralidoxime was even greater after guanethidine or phentolamine pretreatment. Pralidoxime at 200 mg/kg produced an initial vasodepressor response followed by a delayed pressor response. Unlike propranolol, phentolamine eliminated the initial vasodepressor response. Conclusions: Pralidoxime at 40 mg/kg administered with epinephrine improved restoration of spontaneous circulation rate by increasing coronary perfusion pressure in a pig model of cardiac arrest, whereas 120 mg/kg did not improve coronary perfusion pressure or restoration of spontaneous circulation rate. The pressor effect of pralidoxime was unrelated to α‐adrenoceptors and buffered by its vasodepressor action mediated by sympathoinhibition. … (more)
- Is Part Of:
- Journal of the American Heart Association. Volume 9:Issue 5(2020)
- Journal:
- Journal of the American Heart Association
- Issue:
- Volume 9:Issue 5(2020)
- Issue Display:
- Volume 9, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 9
- Issue:
- 5
- Issue Sort Value:
- 2020-0009-0005-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2020-03-03
- Subjects:
- blood pressure -- cardiopulmonary resuscitation -- heart arrest -- hemodynamics
Heart -- Diseases -- Periodicals
Cardiovascular system -- Diseases -- Periodicals
Cerebrovascular disease -- Periodicals
Cardiology -- Periodicals
616.1 - Journal URLs:
- http://jaha.ahajournals.org ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2047-9980 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1161/JAHA.119.015076 ↗
- Languages:
- English
- ISSNs:
- 2047-9980
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15265.xml